How Much Did Medchart Raise?
Funding & Key Investors

Medchart has secured $17M in total funding, with its most recent capital injection amounting to $17M in a major strategic investment. This significant backing underscores the company's pivotal role in the medical record transfer sector and its trajectory towards scaling operations.

What is Medchart?

Medchart
SoftwareHealthcare SoftwareBusiness Services

Medchart specializes in streamlining the medical record transfer process, aiming to reduce the administrative burden on legal and healthcare professionals. The company's proprietary SMART authorizations enable requests to nearly all healthcare facilities nationwide from a single intake, eliminating the need for repeated client signatures. This focus on efficiency and industry-specific solutions positions Medchart as a key player in optimizing healthcare data management and accessibility.

How much funding has Medchart raised?

Medchart has raised a total of $17M across 1 funding round:

2021

Other Financing Round

$17M

Other Financing Round (2021): $17M with participation from Stanford Law School, Nas, Golden Ventures, Vast Ventures, Union Square Ventures, Crosslink Capital, and iGan Partners

Key Investors in Medchart

Stanford Law School

Stanford Law School, a prominent institution in legal education, likely provides strategic insights and potential connections within the legal and regulatory aspects of healthcare data management.

Golden Ventures

Golden Ventures, a venture capital fund focused on early-stage companies, typically invests in innovative technologies and offers mentorship to entrepreneurs, suggesting a belief in Medchart's disruptive potential in the mobile or tech-enabled healthcare space.

iGan Partners

iGan Partners, a leading healthcare-focused venture capital firm, brings specialized expertise and a strong network within the healthcare industry, indicating a strategic alignment with Medchart's mission to improve healthcare solutions.

What's next for Medchart?

The recent major enterprise-level funding indicates Medchart is likely in a growth or scaling phase, poised to expand its market reach and enhance its technological infrastructure. This strategic investment will probably fuel further development of its platform, potentially broadening its service offerings and solidifying its competitive advantage in the health tech industry. The company's emphasis on simplifying complex administrative tasks suggests a continued focus on innovation to address critical pain points within the healthcare ecosystem.

See full Medchart company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Financial SoftwareSoftware
Database & File Management SoftwareSoftwareBusiness Intelligence (BI) Software
Enterprise Resource Planning (ERP)Software
Multimedia, Games & Graphics SoftwareSoftware

Frequently Asked Questions Regarding Medchart Financial Insights

What are the most recent funding rounds that Medchart has completed, and what were the funding rounds?
Medchart has recently completed 1 funding rounds: Other Financing Round on Apr 22, 2021.
What is the total amount of funding Medchart has raised to date?
Medchart has raised a total of $17M in funding to date.
How many funding rounds has Medchart completed?
Medchart has completed 1 funding rounds.
How much funding did Medchart raise in its most recent funding round?
Medchart raised $17M in its most recent funding round.
Who are the lead investors in Medchart's latest funding round?
The lead investor in Medchart's latest funding round was Stanford Law School. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Medchart's history?
The largest funding round in Medchart's history was $17M.
See more information about Medchart